Total Mesorectal Excision
Cross-source consensus on Total Mesorectal Excision from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Risks & contraindications
Other
Highlighted claims
- TME is the current standard of care for early-stage rectal cancer because of proven oncological efficacy. — Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study
- TME carries perioperative and long-term morbidity that can impair quality of life. — Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study
- Patients with poor or no response at the first assessment are strongly advised to proceed to TME without delay. — Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study
- Patients who undergo completion or salvage TME return to standard national colorectal cancer follow-up guidelines. — Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study